Synopsis

There is increasing data describing abnormalities present on patients who have had CMR post SARS-CoV2 infection, especially in patients with troponin elevation and/or cardiac symptoms. These findings include infarct and myocarditis pattern late gadolinium enhancement, elevated T1, T2, and extracellular fraction levels. Controversy exists regarding whether or not these findings can be attributed to SARS-CoV2. Thus, we began by describing the definitions of myocarditis, the updated Lake Louise criteria for CMR for myocardial inflammation, and autopsy evidence of myocarditis associated with SARS-CoV2, and then go into the findings in the current literature.